title: Safety and efficacy of vigabatrin and carbamazepine. CPMP. The Committee for Proprietary Medicinal Products.
authors.forename: A J
authors.initials: AJ
authors.lastname: Elferink
authors.forename: M
authors.initials: M
authors.lastname: Toivonen
authors.forename: H
authors.initials: H
authors.lastname: van Bronswijk
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D002220:Carbamazepine / Q000627:therapeutic use*; D002648:Child; D004828:Epilepsies, Partial / Q000188:drug therapy*; D006801:Humans; D018570:Risk Assessment; D020888:Vigabatrin / Q000009:adverse effects*; D014794:Visual Fields / Q000187:drug effects
chemical_list: D000927:Anticonvulsants; D002220:Carbamazepine; D020888:Vigabatrin